These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38373652)

  • 1. Anti-steatotic effects of PPAR-alpha and gamma involve gut-liver axis modulation in high-fat diet-fed mice.
    Vasques-Monteiro IML; Fernandes-da-Silva A; Miranda CS; Silva-Veiga FM; Daleprane JB; Souza-Mello V
    Mol Cell Endocrinol; 2024 May; 585():112177. PubMed ID: 38373652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor-alpha activation and dipeptidyl peptidase-4 inhibition target dysbiosis to treat fatty liver in obese mice.
    Silva-Veiga FM; Miranda CS; Vasques-Monteiro IML; Souza-Tavares H; Martins FF; Daleprane JB; Souza-Mello V
    World J Gastroenterol; 2022 May; 28(17):1814-1829. PubMed ID: 35633911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Singular effects of PPAR agonists on nonalcoholic fatty liver disease of diet-induced obese mice.
    Barbosa-da-Silva S; Souza-Mello V; Magliano DC; Marinho Tde S; Aguila MB; Mandarim-de-Lacerda CA
    Life Sci; 2015 Apr; 127():73-81. PubMed ID: 25748419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptors-alpha and gamma are targets to treat offspring from maternal diet-induced obesity in mice.
    Magliano DC; Bargut TC; de Carvalho SN; Aguila MB; Mandarim-de-Lacerda CA; Souza-Mello V
    PLoS One; 2013; 8(5):e64258. PubMed ID: 23700465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut-liver axis modulation in fructose-fed mice: a role for PPAR-alpha and linagliptin.
    Silva-Veiga FM; Miranda CS; Martins FF; Daleprane JB; Mandarim-de-Lacerda CA; Souza-Mello V
    J Endocrinol; 2020 Oct; 247(1):11-24. PubMed ID: 32698143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice.
    Park HS; Hur HJ; Kim SH; Park SJ; Hong MJ; Sung MJ; Kwon DY; Kim MS
    Mol Nutr Food Res; 2016 Sep; 60(9):1944-55. PubMed ID: 27145114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ascorbic acid inhibits visceral obesity and nonalcoholic fatty liver disease by activating peroxisome proliferator-activated receptor α in high-fat-diet-fed C57BL/6J mice.
    Lee H; Ahn J; Shin SS; Yoon M
    Int J Obes (Lond); 2019 Aug; 43(8):1620-1630. PubMed ID: 30283077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis.
    Vitaglione P; Mazzone G; Lembo V; D'Argenio G; Rossi A; Guido M; Savoia M; Salomone F; Mennella I; De Filippis F; Ercolini D; Caporaso N; Morisco F
    J Nutr Sci; 2019; 8():e15. PubMed ID: 31037218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kefir alleviates obesity and hepatic steatosis in high-fat diet-fed mice by modulation of gut microbiota and mycobiota: targeted and untargeted community analysis with correlation of biomarkers.
    Kim DH; Kim H; Jeong D; Kang IB; Chon JW; Kim HS; Song KY; Seo KH
    J Nutr Biochem; 2017 Jun; 44():35-43. PubMed ID: 28384519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptors-alpha and gamma synergism modulate the gut-adipose tissue axis and mitigate obesity.
    Miranda CS; Silva-Veiga FM; Fernandes-da-Silva A; Guimarães Pereira VR; Martins BC; Daleprane JB; Martins FF; Souza-Mello V
    Mol Cell Endocrinol; 2023 Feb; 562():111839. PubMed ID: 36581062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise enhances hepatic mitochondrial structure and function while preventing endoplasmic reticulum stress and metabolic dysfunction-associated steatotic liver disease in mice fed a high-fat diet.
    Souza-Tavares H; Santana-Oliveira DA; Vasques-Monteiro IML; Silva-Veiga FM; Mandarim-de-Lacerda CA; Souza-Mello V
    Nutr Res; 2024 Jun; 126():180-192. PubMed ID: 38759501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced liver steatosis accompanies an increase in hepatic inflammation, colonic, secondary bile acids and Lactobacillaceae/Lachnospiraceae bacteria in C57BL/6 mice fed a high-fat diet.
    Zeng H; Larson KJ; Cheng WH; Bukowski MR; Safratowich BD; Liu Z; Hakkak R
    J Nutr Biochem; 2020 Apr; 78():108336. PubMed ID: 32004929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
    Wang P; Wang J; Li D; Ke W; Chen F; Hu X
    J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-obesogenic effects of WY14643 (PPAR-alpha agonist): Hepatic mitochondrial enhancement and suppressed lipogenic pathway in diet-induced obese mice.
    Veiga FMS; Graus-Nunes F; Rachid TL; Barreto AB; Mandarim-de-Lacerda CA; Souza-Mello V
    Biochimie; 2017 Sep; 140():106-116. PubMed ID: 28711683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Peroxisome Proliferator-Activated Receptor Agonists on Myosteatosis in the Context of Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Boliaki N; Henin G; Bale G; Lanthier N
    Discov Med; 2024 Jun; 36(185):1139-1153. PubMed ID: 38926100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Green tea extract increases adiponectin and PPAR α levels to improve hepatic steatosis.
    Marinovic MP; Sousa-Filho CPB; Batista FAH; Avelino TM; Cogliati B; Figueira ACM; Otton R; Rodrigues AC
    J Nutr Biochem; 2022 May; 103():108957. PubMed ID: 35134507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatobiliary and pancreatic: Multi-donor fecal microbiota transplantation attenuated high-fat diet-induced hepatic steatosis in mice by remodeling the gut microbiota.
    Shou D; Luo Q; Tang W; Cao C; Huang H; Chen H; Zhou Y
    J Gastroenterol Hepatol; 2023 Dec; 38(12):2195-2205. PubMed ID: 37787118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of bifid triple viable on chronic low-grade inflammation in obese mice induced by high fat diet].
    Lu M; Yuan L; Hu N; Zhong X; Jiang Y; Lin M; Lu X
    Wei Sheng Yan Jiu; 2022 Sep; 51(5):797-802. PubMed ID: 36222043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota induces hepatic steatosis by modulating the T cells balance in high fructose diet mice.
    Zhou X; Zhang X; Niu D; Zhang S; Wang H; Zhang X; Nan F; Jiang S; Wang B
    Sci Rep; 2023 Apr; 13(1):6701. PubMed ID: 37095192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.